$NEOV
NeoVolta Inc.

2022 Q3 Form 10-K Financial Statement

#000168316822006609 Filed on September 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022
Revenue $1.538M $905.9K $4.474M
YoY Change -3.86% -5.63% -7.26%
Cost Of Revenue $1.292M $773.1K $3.806M
YoY Change -5.07% -6.52% -8.85%
Gross Profit $245.9K $132.8K $667.1K
YoY Change 3.05% -0.07% 3.0%
Gross Profit Margin 15.99% 14.66% 14.91%
Selling, General & Admin $919.4K $1.240M $6.354M
YoY Change 155.4% 114.99% -23.04%
% of Gross Profit 373.94% 933.75% 952.42%
Research & Development $20.90K $2.000K $68.50K
YoY Change 391.42% 60.05%
% of Gross Profit 8.5% 1.51% 10.27%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $940.3K $1.242M $6.422M
YoY Change 160.62% 115.33% -22.61%
Operating Profit -$694.5K -$1.109M -$5.755M
YoY Change 468.29% 149.88% -24.78%
Interest Expense $4.134K -$18.18K $49.54K
YoY Change 636.9% 173.38% 102.05%
% of Operating Profit
Other Income/Expense, Net -$4.134K -$49.54K
YoY Change 636.9% -1075.47%
Pretax Income -$698.6K -$1.127M -$5.805M
YoY Change 437.38% 150.23% -24.08%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$698.6K -$1.127M -$5.805M
YoY Change 469.06% 150.23% -24.08%
Net Earnings / Revenue -45.43% -124.42% -129.76%
Basic Earnings Per Share -$0.02 -$0.28
Diluted Earnings Per Share -$0.02 -$54.83K -$0.28
COMMON SHARES
Basic Shares Outstanding 32.77M shares 20.55M shares
Diluted Shares Outstanding 29.01M shares 20.55M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.993M $330.4K $330.4K
YoY Change -22.39%
Cash & Equivalents $3.993M $330.4K $330.4K
Short-Term Investments
Other Short-Term Assets $107.5K $239.0K $239.0K
YoY Change 420.36%
Inventory $1.637M $2.238M $2.238M
Prepaid Expenses
Receivables $2.076M $1.318M $1.318M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.813M $4.125M $4.125M
YoY Change 26.46% 26.46%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $7.813M $4.125M $4.125M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $7.813M $4.125M $4.125M
YoY Change 26.46% 26.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $205.6K $205.6K
YoY Change 284.23% 284.23%
Accrued Expenses $342.7K $180.8K $180.8K
YoY Change 343.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.068M $1.068M
YoY Change
Total Short-Term Liabilities $342.6K $1.454M $1.454M
YoY Change 1443.14% 1443.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $53.72K $53.72K
YoY Change 178.2%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $53.72K $53.72K
YoY Change 178.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $342.6K $1.454M $1.454M
Total Long-Term Liabilities $0.00 $53.72K $53.72K
Total Liabilities $342.6K $1.508M $1.508M
YoY Change 1228.06% 1228.03%
SHAREHOLDERS EQUITY
Retained Earnings -$16.50M -$15.80M
YoY Change 57.36%
Common Stock $32.77K $21.98K
YoY Change 11.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.470M $2.617M $2.617M
YoY Change
Total Liabilities & Shareholders Equity $7.813M $4.125M $4.125M
YoY Change 26.46% 26.46%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022
OPERATING ACTIVITIES
Net Income -$698.6K -$1.127M -$5.805M
YoY Change 469.06% 150.23% -24.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$118.1K -$455.6K -$1.163M
YoY Change -37.0% 9.97% 31.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.780M 0.000 $1.068M
YoY Change
NET CHANGE
Cash From Operating Activities -$118.1K -455.6K -$1.163M
Cash From Investing Activities
Cash From Financing Activities $3.780M 0.000 $1.068M
Net Change In Cash $3.662M -455.6K -$95.30K
YoY Change -2053.0% 9.97% -89.22%
FREE CASH FLOW
Cash From Operating Activities -$118.1K -$455.6K -$1.163M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001748137
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41447
CY2022 dei Entity Registrant Name
EntityRegistrantName
NeoVolta, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5299263
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
13651 Danielson Street
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Poway
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92064
CY2022 dei City Area Code
CityAreaCode
(800)
CY2022 dei Local Phone Number
LocalPhoneNumber
364-5464
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Public Float
EntityPublicFloat
197800000 usd
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32770368 shares
CY2022 dei Auditor Firm
AuditorFirmId
206
CY2022 dei Auditor Name
AuditorName
MaloneBailey, LLP
CY2022 dei Auditor Location
AuditorLocation
Houston, Texas
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
330385 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
425681 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1317738 usd
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1128444 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2238208 usd
CY2021Q2 us-gaap Inventory Net
InventoryNet
1662140 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
239001 usd
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
45926 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
4125332 usd
CY2021Q2 us-gaap Assets Current
AssetsCurrent
3262191 usd
CY2022Q2 us-gaap Assets
Assets
4125332 usd
CY2021Q2 us-gaap Assets
Assets
3262191 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
205600 usd
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
53510 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
53436 usd
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
3918 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
127356 usd
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36821 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1068000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1454392 usd
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
94249 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2021Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
41307 usd
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
53716 usd
CY2021Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
19308 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1508108 usd
CY2021Q2 us-gaap Liabilities
Liabilities
113557 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21977251 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21977251 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19640888 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19640888 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
21978 usd
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
19641 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18394641 usd
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13169363 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15799395 usd
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10040370 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2617224 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3148634 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4125332 usd
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3262191 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4473514 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4823510 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3806381 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4175795 usd
CY2022 us-gaap Gross Profit
GrossProfit
667133 usd
CY2021 us-gaap Gross Profit
GrossProfit
647715 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6353920 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8255865 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
68503 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42801 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
6422423 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
8298666 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-5755290 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-7650951 usd
CY2022 us-gaap Interest Expense
InterestExpense
49544 usd
CY2021 us-gaap Interest Expense
InterestExpense
24521 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
29600 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-49544 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5079 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5804834 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7645872 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20554985 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20554985 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17889327 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17889327 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
3334406 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
22711 usd
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7437389 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7645872 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3148634 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
6922 usd
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
5307809 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5804834 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2617224 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5804834 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7645872 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
5307809 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7437389 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
21780 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
29600 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
189294 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
737332 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
576068 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
108844 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
193075 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-104089 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
152090 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
49850 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
140076 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
24917 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1163296 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-883623 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1068000 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1068000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-95296 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-883623 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
425681 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1309304 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
330385 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
425681 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 NEOV Convertible Notes Payable And Accrued Interest Converted To Common Stock
ConvertibleNotesPayableAndAccruedInterestConvertedToCommonStock
6922 usd
CY2021 NEOV Convertible Notes Payable And Accrued Interest Converted To Common Stock
ConvertibleNotesPayableAndAccruedInterestConvertedToCommonStock
22711 usd
CY2022 NEOV Adjustment Of Debt Discount Related To Adoption Of New Accounting Principle
AdjustmentOfDebtDiscountRelatedToAdoptionOfNewAccountingPrinciple
87116 usd
CY2021 NEOV Adjustment Of Debt Discount Related To Adoption Of New Accounting Principle
AdjustmentOfDebtDiscountRelatedToAdoptionOfNewAccountingPrinciple
0 usd
CY2022Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
80385 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1845973 usd
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1245945 usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
22768 usd
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
416195 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
369467 usd
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2238208 usd
CY2021Q2 us-gaap Inventory Net
InventoryNet
1662140 usd
CY2022 us-gaap Revenue Recognition Allowances
RevenueRecognitionAllowances
<p id="xdx_848_eus-gaap--RevenueRecognitionAllowances_zuAnR4vVd257" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_863_zKpSVSMucCUe">Allowance for Doubtful Accounts</span></i> – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of June 30, 2022, <span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20220630_z4hh7HLfbfJ8">no</span> allowance for doubtful accounts has been recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1068000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_znhFt6cWjX3d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86A_zNhaXHlUxEL6">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2022Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0 usd
CY2022 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
6922 usd
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
22711 usd
CY2022 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1098630 shares
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3604830 shares
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
53716 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
1121716 usd
CY2022 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
6922 usd
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
22711 usd
CY2022 NEOV Debt Conversion Converted Instrument Shares1
DebtConversionConvertedInstrumentShares1
1098630 shares
CY2021 NEOV Debt Conversion Converted Instrument Shares1
DebtConversionConvertedInstrumentShares1
3604830 shares
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7437389 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
104400 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
39200 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
104400 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
39200 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
414600 usd
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
310200 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
414600 usd
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
310200 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1974000 usd

Files In Submission

Name View Source Status
0001683168-22-006609-index-headers.html Edgar Link pending
0001683168-22-006609-index.html Edgar Link pending
0001683168-22-006609.txt Edgar Link pending
0001683168-22-006609-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
image_004.jpg Edgar Link pending
image_005.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
neov-20220630.xsd Edgar Link pending
neovolta_ex0406.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
neov-20220630_pre.xml Edgar Link unprocessable
neov-20220630_lab.xml Edgar Link unprocessable
neov-20220630_def.xml Edgar Link unprocessable
neovolta_ex3101.htm Edgar Link pending
neovolta_ex3102.htm Edgar Link pending
neovolta_ex3201.htm Edgar Link pending
neovolta_ex3202.htm Edgar Link pending
neovolta_i10k-063022.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
neov-20220630_cal.xml Edgar Link unprocessable
neovolta_i10k-063022_htm.xml Edgar Link completed